CA2065434A1 - Derives de la pyrrolo[2,3-d]pyrimidine; methode de preparation; composition pharmaceutique renfermant ce type de derive comme principe actif - Google Patents

Derives de la pyrrolo[2,3-d]pyrimidine; methode de preparation; composition pharmaceutique renfermant ce type de derive comme principe actif

Info

Publication number
CA2065434A1
CA2065434A1 CA2065434A CA2065434A CA2065434A1 CA 2065434 A1 CA2065434 A1 CA 2065434A1 CA 2065434 A CA2065434 A CA 2065434A CA 2065434 A CA2065434 A CA 2065434A CA 2065434 A1 CA2065434 A1 CA 2065434A1
Authority
CA
Canada
Prior art keywords
same
pyrrolo
pharmaceutical preparation
producing
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2065434A
Other languages
English (en)
Other versions
CA2065434C (fr
Inventor
Yasuji Sakuma
Masaichi Hasegawa
Kenichiro Kataoka
Kenji Hoshina
Noboru Yamazaki
Takashi Kadota
Hisao Yamaguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2065434A1 publication Critical patent/CA2065434A1/fr
Application granted granted Critical
Publication of CA2065434C publication Critical patent/CA2065434C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA002065434A 1989-09-19 1990-09-19 Derives de la pyrrolo[2,3-d]pyrimidine; methode de preparation; composition pharmaceutique renfermant ce type de derive comme principe actif Expired - Fee Related CA2065434C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP1-242933 1989-09-19
JP24293389 1989-09-19
PCT/JP1990/001200 WO1991004254A1 (fr) 1989-09-19 1990-09-19 DERIVE DE PYRROLO[2,3-d]PYRIMIDINE, SON PROCEDE DE PREPARATION, ET PREPARATION PHARMACEUTIQUE COMPRENANT LE DERIVE COMME INGREDIENT ACTIF

Publications (2)

Publication Number Publication Date
CA2065434A1 true CA2065434A1 (fr) 1991-03-20
CA2065434C CA2065434C (fr) 1999-11-30

Family

ID=17096378

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002065434A Expired - Fee Related CA2065434C (fr) 1989-09-19 1990-09-19 Derives de la pyrrolo[2,3-d]pyrimidine; methode de preparation; composition pharmaceutique renfermant ce type de derive comme principe actif

Country Status (7)

Country Link
EP (1) EP0514540B1 (fr)
KR (1) KR970009225B1 (fr)
AT (1) ATE140457T1 (fr)
AU (1) AU641183B2 (fr)
CA (1) CA2065434C (fr)
DE (1) DE69027862T2 (fr)
WO (1) WO1991004254A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2541702B2 (ja) * 1989-10-11 1996-10-09 帝人株式会社 二環性ピリミジン誘導体、その製造方法およびそれを有効成分とする医薬製剤
US5196424A (en) * 1992-03-24 1993-03-23 Eli Lilly And Company N-[2-amino-4-substituted[[(pyrrollo or pyrido)[2,3-d]pyrimidinyl]-alkyl]benzoyl]-L-glutamic acids
US5502187A (en) * 1992-04-03 1996-03-26 The Upjohn Company Pharmaceutically active bicyclic-heterocyclic amines
FI944602A0 (fi) * 1992-04-03 1994-10-03 Upjohn Co Farmaseuttisesti aktiiviset bisyklis-heterosykliset amiinit
FR2699176B1 (fr) * 1992-12-11 1995-03-03 Adir Nouveaux composés bicycliques de pyrimidine, leur procédé de préparation et les compositions pharmaceutiques les renfermant.
US5795986A (en) * 1995-03-02 1998-08-18 Pharmacia & Upjohn Company Pyrimido 4,5-B!indoles
ATE217873T1 (de) * 1996-01-23 2002-06-15 Novartis Erfind Verwalt Gmbh Pyrrolopyrimidinen und verfahren zu deren herstellung
AU1794697A (en) * 1996-03-06 1997-09-22 Novartis Ag 7-alkyl-pyrrolo{2,3-d}pyrimidines
US6339089B2 (en) 1997-08-13 2002-01-15 Fujirebio Inc. Pyrimidine nucleus-containing compound and a medicament containing the same for a blood oxygen partial pressure amelioration, and a method for preparing the same
US6878716B1 (en) 1998-06-02 2005-04-12 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptor and uses thereof
YU76100A (sh) 1998-06-02 2003-12-31 Osi Pharmaceuticals Inc. Pirolo(2,3-d) pirimidin preparati i njihova primena
US6686366B1 (en) 1998-06-02 2004-02-03 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
US6664252B2 (en) 1999-12-02 2003-12-16 Osi Pharmaceuticals, Inc. 4-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereof
US7160890B2 (en) 1999-12-02 2007-01-09 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
US6680322B2 (en) 1999-12-02 2004-01-20 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptors and uses thereof
US6673802B2 (en) 2000-12-01 2004-01-06 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
US6680324B2 (en) 2000-12-01 2004-01-20 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptors and uses thereof
DE10148883A1 (de) * 2001-10-04 2003-04-10 Merck Patent Gmbh Pyrimidinderivate
AU2002360436A1 (en) 2001-11-30 2003-06-17 Osi Pharmaceuticals, Inc. 2-aryl pyrrologpyrimidines for a1 and a3 receptors
CN101973998A (zh) 2001-12-20 2011-02-16 Osi药物公司 吡咯并嘧啶A2b选择性拮抗剂化合物
CN1620294A (zh) 2001-12-20 2005-05-25 Osi药物公司 嘧啶a2b选择性拮抗剂化合物,它们的合成及用途
WO2005117909A2 (fr) * 2004-04-23 2005-12-15 Exelixis, Inc. Modulateurs des proteines kinases et leurs methodes d'utilisation
EP2651417B1 (fr) 2010-12-16 2016-11-30 Calchan Limited Dérivés pyrrolopyrimidine inhibant ask1

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3739366A1 (de) * 1987-04-10 1988-10-27 Boehringer Mannheim Gmbh Desaza-purin-nucleosid-derivate, verfahren zu deren herstellung sowie deren verwendung bei der nucleinsaeure-sequenzierung sowie als antivirale mittel
JP2541702B2 (ja) * 1989-10-11 1996-10-09 帝人株式会社 二環性ピリミジン誘導体、その製造方法およびそれを有効成分とする医薬製剤

Also Published As

Publication number Publication date
DE69027862T2 (de) 1997-03-06
AU6400190A (en) 1991-04-18
ATE140457T1 (de) 1996-08-15
EP0514540A4 (en) 1994-07-20
KR970009225B1 (ko) 1997-06-09
WO1991004254A1 (fr) 1991-04-04
EP0514540B1 (fr) 1996-07-17
KR927003591A (ko) 1992-12-18
CA2065434C (fr) 1999-11-30
AU641183B2 (en) 1993-09-16
EP0514540A1 (fr) 1992-11-25
DE69027862D1 (de) 1996-08-22

Similar Documents

Publication Publication Date Title
CA2065434A1 (fr) Derives de la pyrrolo[2,3-d]pyrimidine; methode de preparation; composition pharmaceutique renfermant ce type de derive comme principe actif
CA2382919A1 (fr) Derives d'imidazo-3-yl-amine bicycliques
AU6522090A (en) Bicyclic pyrimidine derivative, method of producing the same, and pharmaceutical preparation containing the same as active ingredient
SG48098A1 (en) N-(pyrrolo[2,3-d]pyrimidin-3-ylacyl)-glutamic acid derivatives
HUT68915A (en) Process for preparing optically active 5h-pyrrolo[3,4-b]pyrazine derivatives and pharmaceutical compositions containing same
HUT61311A (en) Process for producing /1,2,4/triazolo/1,5-a//1,3,5/-traizine and pyrazolo/2,3-a//1,3,5/-triazine derivatives and pharmaceutical compositions comprising same as active ingredient
CA2098256A1 (fr) Derives de l'acide biliaire, leur procede de preparation et leur utilisation comme agents pharmaceutiques
HUP0203450A3 (en) Pyrazolo '4,3-d! pyrimidine derivatives, process for their preparation and pharmaceutical compositions containing them and their use
HUT53888A (en) Fungicides comprising pyrimidine derivatives as active ingredient and process for producing the active ingredients
CA2027608A1 (fr) Agent revitalisant pour les cheveux
CA2093798A1 (fr) Derives pyridine et n-oxyde de pyridine de diaryle methyle piperidines ou piperazines; compositions et methodes de preparation
HUT64065A (en) Process for producing quinolone- and naphthyridonecarboxylic acid derivatives and pharmaceutical compositions comprising same as active ingredient
AU3091489A (en) Piperazine derivative or its salt, process for producing the same and pharmaceutical composition comprising the same as active ingredient
CA2040982A1 (fr) Derives n-(3-fluoro-2-phosphonylmethoxypropyle) des bases heterocycliques purine et pyrimidine, methode pour leur production et utilisation comme principes actifs de medicaments
HUT46657A (en) Process for producing antitumour pharmaceutical compositions comprising sulfonyl-urea derivatives as active ingredient
CA2386813A1 (fr) Derives d'imidazo-3-yl-amine bicycliques substitues sur le sixieme chainon
CA2138289A1 (fr) Derives azabicycloheptane substitues en n, leur preparation et leur utilisation
CA2078662A1 (fr) Derive de 4-desoxy-epipodophyllotoxine ou sel pharmaceutiquement acceptable
HUT53363A (en) Process for producing new perhydroazacycloalkano(1,2-a)imidazole derivatives and pharmaceutical compositions comprising such compounds as active ingredient
CA2187409A1 (fr) Sels d'acide tetrahydrofolique, cristallises, stables
HUT45529A (en) Process for producing pyrazolo/3,4-d/pyrimidine derivatives and pharmaceutics comprising these compounds as active ingredient
HUT49367A (en) Process for producing aristeromycin/adenosine derivatives and pharmaceutical compositions comprising same as active ingredient
GEP19971030B (en) Method for preparation of derivatives of 1-benzil-3-oximetil-indazolului or salts with pharmaceutically acceptable bases
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
CA2127472A1 (fr) Nouveaux derives de l'adenosine; methodes de preparation; compositions pharmaceutiques a base de ces derives

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed
MKLA Lapsed

Effective date: 20040920